CSPC Innovation Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd. Receivables for the year ending December 31, 2023: USD 76.77 M

CSPC Innovation Pharmaceutical Co., Ltd. Receivables is USD 76.77 M for the year ending December 31, 2023, a -26.09% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

CSPC Innovation Pharmaceutical Co., Ltd. Receivables for the year ending December 31, 2022 was USD 103.86 M, a 53.96% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Receivables for the year ending December 31, 2021 was USD 67.46 M, a 44.87% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Receivables for the year ending December 31, 2020 was USD 46.57 M, a -7.29% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Receivables for the year ending December 31, 2019 was USD 50.23 M, a 5.25% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Shenzhen Stock Exchange: 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

CEO	Mr. Feng Han
IPO Date	March 22, 2019
Location	China
Headquarters	No. 36, Fuqiang Western Road
Employees	1,887
Sector	Consumers Staples
Industries Non-Alcoholic Beverages Alcoholic Beverages Consumer Packaged Goods Drugstores & Retail Pharmacies Pharmaceuticals Soft Drinks & Sodas Tobacco

Description

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.

Key trends

Past 5 years